These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16130195)

  • 1. Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.
    Liu Y; Chen L; Peng SY; Chen ZX; Hoang-Vu C
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):913-8. PubMed ID: 16130195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of CD97EGF and its ligand CD55 on marginal epithelium is related to higher stage and depth of tumor invasion of gastric carcinomas.
    Liu Y; Chen L; Peng S; Chen Z; Gimm O; Finke R; Hoang-Vu C
    Oncol Rep; 2005 Dec; 14(6):1413-20. PubMed ID: 16273233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma.
    Han SL; Xu C; Wu XL; Li JL; Liu Z; Zeng QQ
    Int J Colorectal Dis; 2010 Jun; 25(6):695-702. PubMed ID: 20339853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD97 and CD55 in human medullary thyroid carcinomas.
    Mustafa T; Klonisch T; Hombach-Klonisch S; Kehlen A; Schmutzler C; Koehrle J; Gimm O; Dralle H; Hoang-Vu C
    Int J Oncol; 2004 Feb; 24(2):285-94. PubMed ID: 14719104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas.
    Aust G; Steinert M; Schütz A; Boltze C; Wahlbuhl M; Hamann J; Wobus M
    Am J Clin Pathol; 2002 Nov; 118(5):699-707. PubMed ID: 12428789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas.
    Mustafa T; Eckert A; Klonisch T; Kehlen A; Maurer P; Klintschar M; Erhuma M; Zschoyan R; Gimm O; Dralle H; Schubert J; Hoang-Vu C
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):108-19. PubMed ID: 15668483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma.
    Wu J; Lei L; Wang S; Gu D; Zhang J
    J Biomed Biotechnol; 2012; 2012():587672. PubMed ID: 22547928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding.
    Wobus M; Vogel B; Schmücking E; Hamann J; Aust G
    Int J Cancer; 2004 Dec; 112(5):815-22. PubMed ID: 15386373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
    Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
    Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
    Hamann J; Vogel B; van Schijndel GM; van Lier RA
    J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.
    Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA
    Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue.
    Hamann J; Wishaupt JO; van Lier RA; Smeets TJ; Breedveld FC; Tak PP
    Arthritis Rheum; 1999 Apr; 42(4):650-8. PubMed ID: 10211878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues.
    Steinert M; Wobus M; Boltze C; Schütz A; Wahlbuhl M; Hamann J; Aust G
    Am J Pathol; 2002 Nov; 161(5):1657-67. PubMed ID: 12414513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD97: a dedifferentiation marker in human thyroid carcinomas.
    Aust G; Eichler W; Laue S; Lehmann I; Heldin NE; Lotz O; Scherbaum WA; Dralle H; Hoang-Vu C
    Cancer Res; 1997 May; 57(9):1798-806. PubMed ID: 9135025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent.
    Liu D; Li C; Trojanowicz B; Li X; Shi D; Zhan C; Wang Z; Chen L
    Gastric Cancer; 2016 Jul; 19(3):754-66. PubMed ID: 26233326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.
    Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ
    J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD97 isoforms in gastric carcinoma.
    Liu D; Trojanowicz B; Radestock Y; Fu T; Hammje K; Chen L; Hoang-Vu C
    Int J Oncol; 2010 Jun; 36(6):1401-8. PubMed ID: 20428763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer.
    He Z; Wu H; Jiao Y; Zheng J
    Oncol Lett; 2015 Feb; 9(2):793-797. PubMed ID: 25624904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
    Qian YM; Haino M; Kelly K; Song WC
    Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of CD97 and CD55 levels in the differential diagnosis of tuberculous and malignant pleural effusions.
    Wang C; Jie J; Li D; Liu Y; Gao J; Song L
    Medicine (Baltimore); 2021 Jul; 100(30):e26771. PubMed ID: 34397724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.